Sanofi has appointed Hugo Fry as the new general manager of its UK and Ireland business.
Fry brings over two decades of commercial, strategic and management experience to the Guildford-based branch, most recently from Sanofi Pasteur where he had been vice president and chief marketing officer since January 2015.
Prior to this, Fry served as global project leader for Lixisenatide at Sanofi’s diabetes unit, having moved from TMC Pharma where he served as vice president of medical.
He also brings medical leadership expertise from Boehringer Ingelheim, Linde, Pfizer and the University of Surrey’s Clinical Research Centre.
Fry said: “I am honoured to be appointed as general manager for the UK.
“I am proud and motivated to lead our more than 1,800 UK colleagues, who continuously demonstrate their commitment to serving the people whose lives we touch.
“Our ambition in the UK is to be a partner in improving the nation’s health. We are dedicated to leveraging the unique diversity of our portfolio and strength of our pipeline toempower people to live life to the fullest.”